Secretagogues & GHRH analogues
BlendCJC-1295 + Ipamorelin
GH-axis blend, 5mg of each peptide per vial
VY-BLD-2608-04Tested 2026-09-03
Purchase options
Price
$100
AUD · GST inclusive · $10 per mg
Quantity
1
Same-day dispatch
Orders before 2pm AEST
Tracked express post
Australia Post, 1–3 business days
Discreet packaging
Plain, unbranded outer box
Description
A co-lyophilised blend of CJC-1295 (No DAC) and Ipamorelin, 5mg of each. The GHRH analogue and the ghrelin-receptor agonist act on separate receptors in the pituitary, and their combination is the most widely documented secretagogue pairing in growth-hormone-axis research.
Research notes
- Two independent mechanisms converge on pulsatile GH release
- Short-acting components preserve natural secretion rhythm
- Verified by mass spectrometry for both constituents
Research use only. This compound is supplied for in-vitro and laboratory research. It is not approved by the TGA or any regulatory body for human or veterinary use. Not for human consumption. Handle with appropriate laboratory precautions.
Specifications
- Purity (independent)
- 99.16%
- Molecular formula
- C152H252N44O42 / C38H49N9O5
- Molar mass
- 3367.9 / 711.9 g/mol
- CAS number
- 863288-34-0 / 170851-70-4
- Form
- Lyophilised powder, 10mg total
- Storage
- −20 °C
- Batch
- VY-BLD-2608-04
- Last tested
- 2026-09-03
